BRIEF-Avalon Pharma Q1 Profit SAR 26.9 Million

AVALON PHARMA
Tadawul All Shares Index

AVALON PHARMA

4016.SA

0.00

Tadawul All Shares Index

TASI.SA

0.00

May 6 (Reuters) - Middle East Pharmaceutical Industries Company SJSC 4016.SE:

  • AVALON PHARMA Q1 SALES SAR 130.13 MILLION

  • AVALON PHARMA Q1 NET PROFIT SAR 26.9 MILLION

  • AVALON PHARMA- QUARTER SAW OVERALL GROWTH REMAINED RESILIENT DESPITE GEOPOLITICAL DISRUPTIONS

  • AVALON PHARMA- QUARTER SAW EXPORT SALES REFLECTED A TEMPORARY REPHASING IMPACT

  • AVALON PHARMA- QUARTER SAW NEW CUSTOMER ONBOARDING, STRONGER SELL-OUT RATES, TARGETED TRADE ACTIVATION INITIATIVES

Source text: ID:nSSE6jKh67

Further company coverage: 4016.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.